Franklin Resources Inc. Sells 684,488 Shares of Envista Holdings Corporation $NVST

Franklin Resources Inc. trimmed its position in shares of Envista Holdings Corporation (NYSE:NVSTFree Report) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,067,810 shares of the company’s stock after selling 684,488 shares during the period. Franklin Resources Inc.’s holdings in Envista were worth $175,152,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Dimensional Fund Advisors LP raised its stake in shares of Envista by 4.0% during the third quarter. Dimensional Fund Advisors LP now owns 9,537,874 shares of the company’s stock valued at $194,284,000 after acquiring an additional 367,363 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after acquiring an additional 1,547,656 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock valued at $72,726,000 after acquiring an additional 444,725 shares in the last quarter. Deerfield Management Company L.P. boosted its holdings in Envista by 3.5% in the third quarter. Deerfield Management Company L.P. now owns 2,294,036 shares of the company’s stock valued at $46,730,000 after acquiring an additional 78,191 shares in the last quarter. Finally, Holocene Advisors LP bought a new stake in Envista in the second quarter valued at $43,936,000.

Envista Price Performance

Shares of NVST opened at $24.58 on Wednesday. The stock has a market cap of $4.00 billion, a PE ratio of 59.94, a price-to-earnings-growth ratio of 1.33 and a beta of 0.88. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. Envista Holdings Corporation has a fifty-two week low of $18.25 and a fifty-two week high of $30.42. The firm’s 50-day simple moving average is $25.08 and its two-hundred day simple moving average is $24.65.

Envista (NYSE:NVSTGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.04 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business’s revenue was up 14.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts anticipate that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on NVST. Barclays lifted their price target on shares of Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a report on Wednesday, February 11th. JPMorgan Chase & Co. boosted their price target on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Mizuho boosted their price target on shares of Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a research report on Tuesday, February 10th. Morgan Stanley boosted their price target on shares of Envista from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, April 24th. Finally, Zacks Research lowered Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $28.83.

View Our Latest Research Report on Envista

Envista Profile

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.